Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TOP1 | P11387 | 19/20 | 0.55 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.47 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.47 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31317625 | 1.00 | TOP1 (0.55) | TOP1HDAC3HDAC1HDAC6 | |
| SCHEMBL24642412 | 1.00 | TOP1 (0.55) | TOP1HDAC3HDAC1HDAC6 | |
| SCHEMBL30029279 | 0.90 | TOP1 (0.65) | TOP1 | |
| SCHEMBL24642415 | 0.90 | TOP1 (0.65) | TOP1 | |
| SCHEMBL31576483 | 0.90 | TOP1 (0.65) | TOP1 | |
| SCHEMBL26106876 | 0.86 | TOP1 (0.57) | TOP1HDAC3HDAC1HDAC6 | |
| SCHEMBL24642425 | 0.85 | TOP1 (0.61) | TOP1 | |
| SCHEMBL22230121 | 0.83 | TOP1 (0.66) | TOP1 | |
| SCHEMBL21593899 | 0.82 | TOP1 (0.65) | TOP1 | |
| SCHEMBL21593930 | 0.80 | TOP1 (0.62) | TOP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4748843-A2 | ANTIBODY-DRUG CONJUGATE, AND PREPARATION METHOD THEREFOR AND USE THEREOF | Medilink Therapeutics (Suzhou) Co., Ltd. (CN) | 2026-05-27 | — | — | EP | disclosed |
| EP-4556026-A1 | ANTIBODY-DRUG CONJUGATE, AND PREPARATION METHOD THEREFOR AND USE THEREOF | Medilink Therapeutics (Suzhou) Co., Ltd. (CN) | 2025-05-21 | — | — | EP | disclosed |
| EP-4552654-A1 | ANTIBODY-DRUG CONJUGATE, AND PREPARATION METHOD THEREFOR AND USE THEREOF | Medilink Therapeutics (Suzhou) Co., Ltd. (CN) | 2025-05-14 | — | — | EP | disclosed |